A Single Oral Dose of Thalidomide Enhances the Capacity of Lymphocytes to Secrete Gamma Interferon in Healthy Humans

Thalidomide is increasingly being used as adjuvant therapy for patients with mycobacterial and human immunodeficiency virus (HIV) infections. The T-helper (Th)1 cytokine–Th2 cytokine balance critically determines the outcomes of these diseases. To obtain insight into the effect of thalidomide on the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Verbon, Annelies, Juffermans, Nicole P., Speelman, Peter, van Deventer, Sander J. H., ten Berge, Ineke J. M., Guchelaar, Henk-Jan, van der Poll, Tom
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2000
Gaiak:
Biologic Response Modifiers
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC90059/
https://ncbi.nlm.nih.gov/pubmed/10952569
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak